Engineers Gate Manager’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-55,442
Closed -$159K 2379
2025
Q3
$159K Sell
55,442
-134,695
-71% -$344K ﹤0.01% 1951
2025
Q2
$458K Buy
190,137
+33,712
+22% +$70.9K 0.01% 1519
2025
Q1
$346K Buy
+156,425
New +$618K 0.01% 1628
2024
Q3
Sell
-24,400
Closed -$175K 2294
2024
Q2
$175K Buy
+24,400
New +$211K ﹤0.01% 1667
2024
Q1
Sell
-78,659
Closed -$515K 2163
2023
Q4
$515K Buy
+78,659
New +$508K 0.01% 1162
2022
Q1
Sell
-15,847
Closed -$664K 2147
2021
Q4
$664K Buy
+15,847
New +$642K 0.03% 861

Other funds holding MRVI

Engineers Gate Manager's MRVI Position: Q4 2025 in Review

Engineers Gate Manager sold out of Maravai LifeSciences (MRVI) in Q4 2025, closing a stake of 55,442 shares — an estimated $159K sold.

Engineers Gate Manager first reported a position in MRVI in Q4 2021 and held it in 6 quarters. The position peaked at $664K in Q4 2021. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • Engineers Gate Manager reported no remaining Maravai LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 55,442 Maravai LifeSciences shares in Q4 2025, an estimated $159K.
  • Engineers Gate Manager first reported a position in Maravai LifeSciences in Q4 2021 and held it in 6 quarters.
  • Engineers Gate Manager's Maravai LifeSciences position peaked at $664K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.